articleTop 1% cited
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
Gynecologic Oncology · 2016 · Vol. 143(1) · pp. 3–15
Alexi A. Wright(Dana-Farber Cancer Institute)Kari Bohlke(American Society of Clinical Oncology)Deborah K. Armstrong(Sidney Kimmel Comprehensive Cancer Center)Michael A. Bookman(Arizona Oncology)William A. Cliby(Mayo Clinic in Arizona)Robert L. Coleman(The University of Texas MD Anderson Cancer Center)Don S. Dizon(Harvard University)Joseph J. Kash(Edward Hospital)Larissa A. Meyer(The University of Texas MD Anderson Cancer Center)Kathleen N. Moore(University of Oklahoma)Alexander Olawaiye(University of Pittsburgh Medical Center)Jessica Oldham(Woman's Cancer Foundation)Ritu Salani(The Ohio State University)Dee SparacioWilliam P. Tew(Memorial Sloan Kettering Cancer Center)Ignace Vergote(European Union)Mitchell I. Edelson✉(Abington Memorial Hospital)
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometrial and Cervical Cancer TreatmentsMedicineGynecologic oncologyOvarian cancerOncologyInternal medicinePerioperativeChemotherapyStage (stratigraphy)GuidelineNeoadjuvant therapy
MeSH terms
Carcinoma, Ovarian EpithelialFemaleHumansNeoplasm StagingNeoplasms, Glandular and EpithelialOvarian NeoplasmsChemotherapy, AdjuvantClinical Trials, Phase III as TopicPractice Guidelines as TopicNeoadjuvant Therapy
Funding
- American College of Surgeons
- American Society of Clinical Oncology
- National Institutes of Health
- National Cancer Institute
Citations
363
FWCI
54.55
field-weighted impact
References
61
Percentile
100%
vs. same field & year
Citations per year
References
Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis
Gynecologic Oncology · 2013 · 421 citations
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
Journal of Clinical Oncology · 2003 · 2,051 citations
A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer
JNCI Journal of the National Cancer Institute · 2003 · 1,126 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.